Safe & Effective Malaria Vaccines for All
Vac4All offers a solution to the complex scientific challenge of developing safe, highly effective and affordable malaria vaccines with its unique scientific and technical assets:
- Antigen selection based on human immunity to malaria
- Proven safety, immunogenicity and efficacy of first-generation prototypes
- Biomarker driven design (with development based on immunological mechanisms of protection in humans)
- Technology platform with highly established safety profile and regulatory experience
- Biofusion conjugate patented technology
- Well-tolerated adjuvants
ABOUT US
A biotech company entirely dedicated to the development of malaria vaccines
Our competitive edge stands on:
- Our unique scientific strategy & approach used to discover our lead candidates
- A strategic alliance with Sanofi to safeguard registration and marketing
- Lean management with a compact team of experienced in-house personnel
- A large international network of highly capable group of collaborators with the expertise, infrastructure & capacity needed to maximize the chances of success